Reusable Core Biopsy Instrument Global Market Report 2026

A reusable core biopsy instrument is a medical device used to extract a cylindrical tissue specimen from the body for diagnostic evaluation. It is designed for multiple uses following appropriate sterilization, providing durability and precision during tissue sampling procedures. A reusable core biopsy instrument supports consistent specimen quality while enabling more cost-efficient clinical workflows over an extended period.

The primary product types of reusable core biopsy instruments include reusable core biopsy needles, reusable biopsy guns, reusable automated biopsy instruments, and reusable semi-automated biopsy instruments. Reusable core biopsy needles refer to sterilizable medical devices designed for repeated tissue core sampling for histopathological examination while delivering reliable sampling performance across multiple procedures. These instruments support ultrasound-guided biopsy, computed tomography-guided biopsy, magnetic resonance imaging-guided biopsy, stereotactic-guided biopsy, and other procedural guidance methods and are available as spring-loaded automated biopsy instruments, vacuum-assisted reusable biopsy devices, manual core biopsy instruments, and pneumatically driven biopsy instruments. The various applications include breast biopsy, prostate biopsy, lung biopsy, liver biopsy, kidney biopsy, bone and bone marrow biopsy, soft tissue biopsy, and others, and these instruments are used by several end users such as hospitals, diagnostic centers, specialty clinics, ambulatory surgical centers, and academic and research institutes.

Tariffs are influencing the reusable core biopsy instrument market by raising the cost of imported medical-grade materials, precision components, and specialized manufacturing equipment needed to produce biopsy devices. This is affecting categories such as reusable core biopsy needles, biopsy guns, and automated biopsy instruments, particularly across import-dependent regions including North America, Europe, and Asia-Pacific. The resulting cost increases are placing pressure on hospitals, diagnostic centers, and specialty clinics through higher procurement expenses and supply chain difficulties. However, tariffs are also promoting local manufacturing, regional supplier diversification, and domestic medical device production, supporting greater long-term supply chain stability and market resilience.

The reusable core biopsy instrument market research report is one of a series of new reports from The Business Research Company that provides reusable core biopsy instrument market statistics, including reusable core biopsy instrument industry global market size, regional shares, competitors with a reusable core biopsy instrument market share, detailed reusable core biopsy instrument market segments, market trends and opportunities, and any further data you may need to thrive in the reusable core biopsy instrument industry. This reusable core biopsy instrument market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The reusable core biopsy instrument market size has grown strongly in recent years. It will grow from $1.03 billion in 2025 to $1.13 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising incidence of cancer and chronic illnesses, increasing need for precise diagnostic procedures, wider adoption of image-guided biopsy methods, continued development of healthcare infrastructure, and growing preference for cost-efficient reusable medical instruments.

The reusable core biopsy instrument market size is expected to see strong growth in the next few years. It will grow to $1.62 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing demand for advanced tissue sampling procedures, growing emphasis on sustainable reusable healthcare devices, rising adoption of precision biopsy workflows, expanding diagnostic screening initiatives, increasing demand for durable and high-performance biopsy instruments. Major trends in the forecast period include growing adoption of reusable precision biopsy instruments, increasing demand for cost-effective tissue sampling solutions, rising emphasis on enhanced sterilization and extended device longevity, increasing preference for consistent diagnostic sample quality, expanding adoption of minimally invasive biopsy procedures.

The rising incidence of cancer and chronic diseases is expected to propel the growth of the reusable core biopsy instrument market going forward. Cancer is a disease characterized by the uncontrolled growth of abnormal cells that can spread throughout the body, while chronic diseases are long-term health conditions that develop gradually and require continuous management. Cancer and chronic diseases are increasing primarily due to unhealthy lifestyles, including poor diet, physical inactivity, smoking, and alcohol consumption, which progressively damage the body over time. Reusable core biopsy instruments support the diagnosis of cancer and chronic diseases by enabling precise tissue sampling, allowing healthcare professionals to accurately determine the type and stage of a disease at an early stage and guide appropriate treatment decisions. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition in 2023. Therefore, the rising incidence of cancer and chronic diseases is driving the growth of the reusable core biopsy instrument market.

The increasing adoption of minimally invasive procedures is expected to propel the growth of the reusable core biopsy instrument market going forward. Minimally invasive procedures are medical treatments that involve small incisions or natural body openings and specialized instruments to reduce tissue damage, pain, and recovery time compared to conventional open surgery. The use of minimally invasive procedures is increasing as patients seek faster recovery, reduced pain, and shorter hospital stays, while healthcare systems benefit from lower overall treatment costs and greater operational efficiency. Reusable core biopsy instruments support minimally invasive procedures by allowing healthcare professionals to obtain accurate tissue samples through small incisions with high precision, reducing the need for open surgical techniques and helping minimize patient trauma and recovery time. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based organization, minimally invasive procedures increased by 7% in 2023 compared to the previous year. Therefore, the increasing adoption of minimally invasive procedures is driving the growth of the reusable core biopsy instrument market.

Key companies operating in the reusable core biopsy instrument market are increasingly prioritizing integrated biopsy systems with adjustable actuation and precision tissue-sampling capabilities to improve biopsy accuracy, preserve tissue integrity, and support reliable pathological diagnosis. These systems combine reusable actuator instruments with biopsy needles designed to obtain full-length, unbroken tissue cores, enabling clinicians to collect representative samples while controlling sampling depth and reducing the risk of under- or overshooting the target. For example, in January 2025, Triopsy Medical, Inc., a US-based medical device company, received FDA 510(k) clearance for its Triopsy Integrated Biopsy System, comprising the Triopsy Actuator and Triopsy Biopsy Needle. The FDA classified the device as a gastroenterology-urology biopsy instrument, and the cleared system uses a reusable actuator with a disposable biopsy needle for prostate tissue sampling. The needle incorporates patented ridges designed to hold and protect the tissue sample, while the actuator provides variable sample lengths for different prostate biopsy locations. By combining a reusable actuation platform with precision tissue-sampling technology, the Triopsy system supports more controlled prostate biopsies and aims to improve the quality and integrity of tissue cores used for pathological assessment.

Major companies operating in the reusable core biopsy instrument market are Becton Dickinson and Company (BD), Cook Group Inc. / Cook Medical, Argon Medical Devices Inc., STERYLAB S.r.l., MDL S.r.l., BIP Medical S.r.l. / BIP GmbH, UROMED Kurt Drews GmbH, GEOTEK MEDICAL, Biomedical Srl, Iscon Surgicals Ltd., Chamfond Biotech Co. Ltd., Vigeo S.r.l., Histo S.r.l., SteryMed S.r.l., Advin Health Care, Meditech Devices Pvt. Ltd., Matek Medical, Adria Medical

North America was the dominant region in the reusable core biopsy instrument market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the reusable core biopsy instrument market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the reusable core biopsy instrument market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The reusable core biopsy instrument market consists of sales of reusable biopsy introducer sets, reusable tissue sampling cannulas, and reusable biopsy guide systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Reusable Core Biopsy Instrument Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses reusable core biopsy instrument market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for reusable core biopsy instrument ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The reusable core biopsy instrument market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Reusable Core Biopsy Needles; Reusable Biopsy Guns; Reusable Automated Biopsy Instruments; Reusable Semi Automated Biopsy Instruments
• 2) By Procedure Guidance: Ultrasound Guided Biopsy; Computed Tomography Guided Biopsy; Magnetic Resonance Imaging Guided Biopsy; Stereotactic Guided Biopsy; Other Procedure Guidances
• 3) By Mechanism Type: Spring Loaded Automated Biopsy Instruments; Vacuum Assisted Reusable Biopsy Devices; Manual Core Biopsy Instruments; Pneumatic Driven Biopsy Instruments
• 4) By Application: Breast Biopsy; Prostate Biopsy; Lung Biopsy; Liver Biopsy; Kidney Biopsy; Bone And Bone Marrow Biopsy; Soft Tissue Biopsy; Other Applications
• 5) By End User: Hospitals; Diagnostic Centers; Specialty Clinics; Ambulatory Surgical Centers; Academic And Research Institutes
• Subsegments:
• 1) By Reusable Core Biopsy Needles: Single Action Core Biopsy Needles; Double Action Core Biopsy Needles; Coaxial Core Biopsy Needles; Echogenic Core Biopsy Needles; Adjustable Throw Length Core Biopsy Needles
• 2) By Reusable Biopsy Guns: Single Handed Reusable Biopsy Guns; Two Handed Reusable Biopsy Guns; Adjustable Throw Reusable Biopsy Guns; Lightweight Reusable Biopsy Guns; Universal Compatibility Reusable Biopsy Guns
• 3) By Reusable Automated Biopsy Instruments: Fully Automated Core Biopsy Instruments; Spring Loaded Automated Biopsy Instruments; Dual Stage Automated Biopsy Instruments; Adjustable Penetration Automated Biopsy Instruments; High Speed Automated Biopsy Instruments
• 4) By Reusable Semi Automated Biopsy Instruments: Single Action Semi Automated Biopsy Instruments; Two Stage Semi Automated Biopsy Instruments; Adjustable Throw Semi Automated Biopsy Instruments; Coaxial Compatible Semi Automated Biopsy Instruments; Precision Control Semi Automated Biopsy Instruments
• Companies Mentioned: Becton Dickinson and Company (BD); Cook Group Inc. / Cook Medical; Argon Medical Devices Inc.; STERYLAB S.r.l.; MDL S.r.l.; BIP Medical S.r.l. / BIP GmbH; UROMED Kurt Drews GmbH; GEOTEK MEDICAL; Biomedical Srl; Iscon Surgicals Ltd.; Chamfond Biotech Co. Ltd.; Vigeo S.r.l.; Histo S.r.l.; SteryMed S.r.l.; Advin Health Care; Meditech Devices Pvt. Ltd.; Matek Medical; Adria Medical
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.